左卡尼汀辅助治疗对重症监护室患者实验室监测指标的影响:一项双盲随机对照临床试验
这项前瞻性双盲随机对照试验在医疗重症监护室纳入54例年龄大于18岁的多病种患者,随机给予每日3克左卡尼汀或安慰剂并联合肠内营养,持续1周。51例完成试验,结果显示干预组较对照组血清白蛋白、总蛋白和钙显著升高,丙氨酸转氨酶、乳酸、肌酐和国际标准化比值显著降低。
要点
- 干预组较对照组血清白蛋白(P=0.001)、总蛋白(P=0.003)和钙(P=0.044)显著升高。
- 干预组较对照组丙氨酸转氨酶(P=0.022)、乳酸(P<0.001)、肌酐(P=0.005)和国际标准化比值(P=0.049)显著降低。
- 左卡尼汀辅助治疗可改善重症患者国际标准化比值、肌酐、丙氨酸转氨酶、乳酸、钙、白蛋白和总蛋白等多项指标。
核心结论
- 左卡尼汀补充可改善重症患者国际标准化比值、肌酐、丙氨酸转氨酶、乳酸、钙、白蛋白和总蛋白等多项参数。
研究设计与样本
- 前瞻性双盲随机对照试验在医疗重症监护室实施,纳入54例年龄大于18岁的多病种患者,随机接受每日3克左卡尼汀或安慰剂并联合肠内营养,持续1周,51例完成试验。
主要发现
- 干预组较对照组血清白蛋白显著升高(P=0.001)。
- 干预组较对照组总蛋白显著升高(P=0.003)。
- 干预组较对照组钙显著升高(P=0.044)。
- 干预组较对照组丙氨酸转氨酶显著降低(P=0.022)。
- 干预组较对照组乳酸显著降低(P<0.001)。
关键数值与推荐
- 干预组较对照组肌酐显著降低(P=0.005)。
- 干预组较对照组国际标准化比值显著降低(P=0.049)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critically ill patients must be monitored constantly in intensive care units (ICUs). Among many laboratory variables, nutritional status indicators are a key role in the prognosis of diseases. We investigated the effects of L-carnitine adjunctive therapy on monitoring variables in critical illness. METHOD: A prospective, double-blind, randomized controlled trial was implemented in a medical ICU. Participants were 54 patients, aged > 18 years, with multiple conditions, randomly assigned to receive 3 g L-carnitine per day or placebo, along with enteral feeding, for 1 week. Primary outcomes included monitoring variables related to nutritional status. RESULT: Of 54 patients randomly assigned, 51 completed the trial. Serum albumin (Alb) (P-value: 0.001), total protein (P-value: 0.003), and calcium (Ca) (0.044) significantly increased in the intervention vs. control group. Alanine transaminase (ALT) (0.022), lactate (<0.001), creatinine (Cr) (0.005), and international normalized ratio (INR) (0.049) decreased meaningfully in the intervention vs. control group. CONCLUSION: L-Carnitine supplementation in critically ill patients can improve several parameters including INR, Cr, ALT, lactate, Ca, Alb, and total protein. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT 20151108024938N2. This trial was approved by the Research Ethics Committee of Mashhad University of Medical Sciences (registration code: IR.MUMS.fm.REC.1396.671) (available at https://en.irct.ir/trial/30748 , May 2018).
引用
- Yahyapoor F, Keshani M, Sedaghat A, et al. The effects of adjunctive treatment with L-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial. Trials. 2023. PMID: 36597167. doi:10.1186/s13063-022-07010-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。